Related Experiment Video
Updated: Mar 14, 2026

Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021
Crystal Structure of the Escherichia coli Fic Toxin-Like Protein in Complex with Its Cognate Antitoxin
Frédéric V Stanger1,2, Alexander Harms2, Christoph Dehio2
1Focal Area Structural Biology and Biophysics, Biozentrum, University of Basel, Basel, Switzerland.
Abstract:
FIC domain proteins mediate post-translational modifications of target proteins, which typically results in their inactivation. Depending on the conservation of crucial active site residues, the FIC fold serves as structural scaffold for various enzymatic activities, mostly target adenylylation. The founding member of the vast Fic protein family, EcFicT, was identified in Escherichia coli some time ago. The G55R point mutant of EcFicT displays the "filamentation induced by cAMP" (Fic) phenotype at high 3',5'-cyclic adenosine monophosphate (cAMP) concentrations and elevated temperature, but the underlying molecular mechanism and any putative biochemical activity of EcFicT have remained unknown. EcFicT belongs to class I Fic toxin proteins that are encoded together with a small inhibitory protein (antitoxin), named EcFicA in E. coli. Here, we report the crystal structures of two mutant EcFicT/EcFicA complexes (EcFicTG55RA and EcFicTAE28G) both showing close resemblance with the structure of the AMP-transferase VbhT from Bartonella schoenbuchensis in complex with its cognate antitoxin VbhA. However, crucial differences in the active site of EcFicT compared to VbhT and other AMP-transferases rationalize the lack of evidence for adenylylation activity. Comprehensive bioinformatic analysis suggests that EcFicT has evolved from canonical AMP-transferases and has acquired a conserved binding site for a yet to be discovered novel substrate. The G55R mutation has no effect on structure or thermal stability of EcFicT, such that the molecular basis for its associated Fic phenotype remains elusive. We anticipate that this structure will inspire further bioinformatic and experimental analyses in order to characterize the enzymatic activity of EcFicT and help revealing its physiological role.
Insights
The study reveals the crystal structures of EcFicT/EcFicA complexes, suggesting EcFicT evolved from AMP-transferases but lacks adenylylation activity. Its Fic phenotype mechanism remains elusive, prompting further research into its novel substrate and physiological role.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Microbiology
Background:
- FIC domain proteins are known to modify target proteins, often leading to inactivation.
- EcFicT, a founding member of the Fic protein family in E. coli, is associated with a filamentation induced by cAMP (Fic) phenotype.
- EcFicT belongs to class I Fic toxins, encoded with an antitoxin (EcFicA).
Purpose of the Study:
- To elucidate the molecular mechanism and biochemical activity of EcFicT.
- To determine the structural basis for the Fic phenotype observed in EcFicT mutants.
- To investigate the evolutionary relationship of EcFicT with other Fic proteins.
Main Methods:
- X-ray crystallography was used to determine the structures of two mutant EcFicT/EcFicA complexes.
- Structural comparison was performed with known AMP-transferases like VbhT.
- Comprehensive bioinformatic analysis was conducted to infer evolutionary origins and potential functions.
Main Results:
- The crystal structures of EcFicT/EcFicA complexes resemble that of AMP-transferase VbhT/VbhA.
- Crucial differences in EcFicT's active site suggest a lack of adenylylation activity.
- Bioinformatic analysis indicates EcFicT evolved from AMP-transferases and may bind a novel substrate.
- The G55R mutation did not alter EcFicT's structure or stability, leaving the Fic phenotype's basis unexplained.
Conclusions:
- EcFicT represents an evolutionary divergence from canonical AMP-transferases.
- The study provides structural insights but does not identify EcFicT's specific enzymatic activity or the cause of the Fic phenotype.
- Further bioinformatic and experimental studies are needed to characterize EcFicT's function and physiological role.
Related Concept Videos
Crystal Field Theory - Octahedral Complexes
To explain the observed behavior of transition metal complexes (such as colors), a model involving electrostatic interactions between the electrons from the ligands and the electrons in the unhybridized d orbitals of the central metal atom has been developed. This electrostatic model is crystal field theory (CFT). It helps to understand, interpret, and predict the colors, magnetic behavior, and some structures of coordination compounds of transition metals.
CFT focuses on...
Crystal Field Theory - Tetrahedral and Square Planar Complexes
Crystal field theory (CFT) is applicable to molecules in geometries other than octahedral. In octahedral complexes, the lobes of the dx2−y2 and dz2 orbitals point directly at the ligands. For tetrahedral complexes, the d orbitals remain in place, but with only four ligands located between the axes. None of the orbitals points directly at the tetrahedral ligands. However, the dx2−y2 and dz2 orbitals (along the Cartesian axes) overlap with the ligands less than the dxy,...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

